Guide

Artificial Wombs: How Close Is Ectogenesis to Changing Pregnancy?

As of 2026, no human has been gestated, even partially, in an artificial womb — the technology exists only in animal models. The realistic near-term application is partial ectogenesis to support extremely premature infants, with human trials for that narrower use in advanced planning and possibly beginning within 5–10 years; a full external human pregnancy remains genuinely experimental and, per credible sources, potentially decades away.

Get my personal plan

Key facts

Ectogenesis means gestating a fetus outside a human body, partly or entirely, using an artificial system rather than a uterus.
The foundational research is a 2017 study from the Children's Hospital of Philadelphia (CHOP), where extremely premature lamb fetuses were supported for several weeks in a fluid-filled 'biobag' system, continuing normal lung and brain development outside a womb.
The realistic near-term human application is narrower than 'full pregnancy in a machine': partial ectogenesis, meaning continued gestation support for extremely premature infants after very early birth — essentially an advanced successor to today's neonatal incubators, not a replacement for pregnancy.
First-in-human trials for this premature-infant application are in advanced planning stages as of 2026, with realistic timelines in the 5–10 year range for trials to actually begin — not for the technology to be widely available.
Full ectogenesis — an entire pregnancy from conception to birth outside a human body — remains genuinely experimental. Credible sources describe the remaining technical and ethical barriers as potentially requiring decades to resolve, if the goal is reached at all.

Legal considerations

No jurisdiction has established a specific legal framework for ectogenesis yet, since no human application exists to regulate — expect this to follow, not precede, the first human trials, similar to how IVF regulation developed after the first successful procedures rather than before.
Partial ectogenesis for premature infants raises narrower, more immediate ethical questions (the legal status of a fetus/infant in an artificial support system, informed consent for trial participation) than full ectogenesis, which raises much larger questions about gestational parenthood, surrogacy law, and what 'birth' even means — expect the narrower premature-infant application to reach real-world use, and real regulation, well before the more speculative full-pregnancy scenario.

Timeline

2017: proof of concept in animals — premature lamb fetuses supported for several weeks in the CHOP biobag system, with continued lung and brain development.
2026 (present): first-in-human trials for partial ectogenesis (premature infant support) in advanced planning, not yet underway.
Next 5–10 years: realistic window for those narrower human trials to actually begin, per current planning.
Full ectogenesis (an entire pregnancy outside the body): no credible near-term timeline exists — described as potentially decades away, if achievable at all.

FAQ